Karri A. Bauer

机构：Merck & Co., Inc., Rahway, NJ, USA (United States)

发表论文 85 篇 · 总被引 2689 次 · h-index 29

代表论文

• Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future (2023 · International Journal of Antimicrobial Agents · 被引 29)
• Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation (2022 · BMC Infectious Diseases · 被引 29)
• A Multicenter Comparison of Prevalence and Predictors of Antimicrobial Resistance in Hospitalized Patients Before and During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic (2022 · Open Forum Infectious Diseases · 被引 28)
• Activity of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against clinical Gram-negative isolates—SMART United States 2019–21 (2023 · JAC-Antimicrobial Resistance · 被引 26)
• Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospitals (2023 · Mycoses · 被引 11)
• Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States (2022 · Antibiotics · 被引 8)